An Investigator-Initiated Study to Assess the Efficacy and Degree of Irritation of Ingenol Mebutate 0.015% Gel and Dermasil Lotion Versus Ingenol Mebuate 0.015% Alone in the Treatment of Actinic Keratoses (AK) on the Face.
Phase of Trial: Phase I
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Ingenol mebutate (Primary) ; Dimeticone
- Indications Actinic keratosis
- Focus Therapeutic Use
- 30 Jan 2017 Status changed from active, no longer recruiting to completed.
- 12 May 2016 Planned End Date changed from 1 Feb 2017 to 1 Aug 2016.
- 12 May 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Aug 2016.